LH monthly performance report
Monthly LH research: returns, drawdown, relative strength, seasonality, and key stats.
LH monthly report
—
Key takeaways
- LabCorp (LH) closed August 2026 at $313.96, up 1.54% for the month and +19.16% over the trailing 12 months.
- Year-to-date, LH is +25.14%, outperforming the S&P 500 which has returned +12.89% YTD.
- The stock is trading +16.80% versus its 200-day moving average ($268.81), a bullish technical signal.
- Over the past three years, LH has underperformed the S&P 500 by −26.41%, with a relative strength index reading of 85.7.
- Win rate over the trailing 39 months stands at 59% — 23 positive months versus 16 negative months.
LabCorp ended August 2026 at $313.96, posting a monthly return of +1.54%. The S&P 500 returned +3.05% over the same window, leaving relative performance at −1.51%.
The current quarter stands at +12.82% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +16.80% versus the 200-day moving average ($268.81).
Year-to-date, LH is +25.14% against SPY +12.89%, a gap of +12.26%. The stock is currently −0.68% below its 52-week high, with maximum 3-year drawdown at −17.36%.
| Period | LH | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.52% | −0.20% | +0.72% |
| 1 Week | −0.09% | +3.90% | −3.99% |
| 1 Month | +1.54% | +3.05% | −1.51% |
| 3 Months | +22.26% | +7.11% | +15.14% |
| 6 Months |